Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a consolidated Locations section listing California, Maryland, and Texas (replacing the former state-specific location subsections) and updated the page to revision v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays 'Results Submitted' instead of 'No Results Posted', indicating that study results have been submitted.SummaryDifference0.1%

- Check38 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed (may or may not relate to the study), replaces the previous provenance wording, and the revision tag updated to v3.3.2.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved the government funding status notice, a site-wide banner about potential delays and operating status, which is not part of the study specifics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedThe screenshots show no changes to the core study content (title, eligibility criteria, interventions, outcomes); only minor layout adjustments and updated timestamps are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check88 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.